Birdwatch Note
2024-08-17 20:35:21 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
実際にはレプリコンワクチンは3か月の治験期間中に死因を問わず約八千人中5人のワクチン接種群が死亡し(うちコロナ死1)、プラセボ群は訳八千人中16人が死亡(うちコロナ死9)がなくなり勿論、動画中の人物のような話はこの規模の数でわかる話としては全く起きていません。 https://www.nature.com/articles/s41467-024-47905-1/tables/2 https://www.nature.com/articles/s41467-024-47905-1 日本語資料は下記pdfの28P目,資料の24P目 https://web.archive.org/web/20240120232711/https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_2.pdf なお、当該治験は17.4%程の高齢者が参加しており↓ https://www.nature.com/articles/s41467-024-47905-1/tables/1 ベトナムは年間8000人中56人程がなくなる国です。 https://data.worldbank.org/indicator/SP.DYN.CDRT.IN?locations=VN 診療を要する有害事象を経験した方の数も接種群12.1%,プラセボ群14.6%でした。 https://www.nature.com/articles/s41467-024-47905-1/tables/2
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824826819390198138
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824907893608722820
- noteId - 1824907893608722820
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1723926921645
- tweetId - 1824826819390198138
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 実際にはレプリコンワクチンは3か月の治験期間中に死因を問わず約八千人中5人のワクチン接種群が死亡し(うちコロナ死1)、プラセボ群は訳八千人中16人が死亡(うちコロナ死9)がなくなり勿論、動画中の人物のような話はこの規模の数でわかる話としては全く起きていません。 https://www.nature.com/articles/s41467-024-47905-1/tables/2 https://www.nature.com/articles/s41467-024-47905-1 日本語資料は下記pdfの28P目,資料の24P目 https://web.archive.org/web/20240120232711/https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_2.pdf なお、当該治験は17.4%程の高齢者が参加しており↓ https://www.nature.com/articles/s41467-024-47905-1/tables/1 ベトナムは年間8000人中56人程がなくなる国です。 https://data.worldbank.org/indicator/SP.DYN.CDRT.IN?locations=VN 診療を要する有害事象を経験した方の数も接種群12.1%,プラセボ群14.6%でした。 https://www.nature.com/articles/s41467-024-47905-1/tables/2
Note Ratings
rated at | rated by | |
2024-08-19 11:20:32 -0500 | Rating Details | |
2024-08-19 06:36:07 -0500 | Rating Details | |
2024-08-19 04:06:15 -0500 | Rating Details | |
2024-08-18 20:15:44 -0500 | Rating Details | |
2024-08-18 18:26:33 -0500 | Rating Details | |
2024-08-18 15:53:43 -0500 | Rating Details | |
2024-08-18 14:29:11 -0500 | Rating Details | |
2024-08-18 12:17:10 -0500 | Rating Details | |
2024-08-18 04:54:05 -0500 | Rating Details | |
2024-08-18 04:15:14 -0500 | Rating Details | |
2024-08-18 03:59:43 -0500 | Rating Details | |
2024-08-18 03:51:40 -0500 | Rating Details | |
2024-08-18 03:35:47 -0500 | Rating Details | |
2024-08-18 02:49:42 -0500 | Rating Details | |
2024-08-18 02:13:46 -0500 | Rating Details | |
2024-08-18 02:05:05 -0500 | Rating Details | |
2024-08-18 01:59:05 -0500 | Rating Details | |
2024-08-18 01:33:35 -0500 | Rating Details | |
2024-08-18 01:17:12 -0500 | Rating Details | |
2024-08-18 01:15:51 -0500 | Rating Details | |
2024-08-18 01:12:57 -0500 | Rating Details | |
2024-08-18 01:09:34 -0500 | Rating Details | |
2024-08-18 01:07:46 -0500 | Rating Details | |
2024-08-18 01:05:50 -0500 | Rating Details | |
2024-08-18 01:03:44 -0500 | Rating Details | |
2024-08-18 01:01:10 -0500 | Rating Details | |
2024-08-17 23:14:33 -0500 | Rating Details | |
2024-08-17 23:05:05 -0500 | Rating Details | |
2024-08-17 22:33:33 -0500 | Rating Details | |
2024-08-17 22:06:52 -0500 | Rating Details | |
2024-08-17 21:19:07 -0500 | Rating Details | |
2024-08-17 20:44:15 -0500 | Rating Details | |
2024-08-17 20:07:23 -0500 | Rating Details | |
2024-08-17 19:47:31 -0500 | Rating Details | |
2024-08-17 19:28:10 -0500 | Rating Details | |
2024-08-17 19:18:50 -0500 | Rating Details | |
2024-08-17 19:15:18 -0500 | Rating Details | |
2024-08-17 18:54:16 -0500 | Rating Details | |
2024-08-17 18:47:28 -0500 | Rating Details | |
2024-08-17 18:45:21 -0500 | Rating Details | |
2024-08-17 18:43:52 -0500 | Rating Details | |
2024-08-17 18:31:47 -0500 | Rating Details | |
2024-08-17 18:31:22 -0500 | Rating Details | |
2024-08-17 18:30:46 -0500 | Rating Details | |
2024-08-17 18:27:39 -0500 | Rating Details | |
2024-08-17 18:26:26 -0500 | Rating Details | |
2024-08-17 18:25:14 -0500 | Rating Details | |
2024-08-17 18:14:51 -0500 | Rating Details | |
2024-08-17 18:10:32 -0500 | Rating Details | |
2024-08-17 18:07:00 -0500 | Rating Details | |
2024-08-17 18:06:32 -0500 | Rating Details | |
2024-08-17 17:54:46 -0500 | Rating Details | |
2024-08-17 17:54:38 -0500 | Rating Details | |
2024-08-17 17:47:53 -0500 | Rating Details | |
2024-08-17 17:42:01 -0500 | Rating Details | |
2024-08-17 17:41:08 -0500 | Rating Details | |
2024-08-17 17:37:53 -0500 | Rating Details | |
2024-08-17 17:37:16 -0500 | Rating Details | |
2024-08-17 17:31:47 -0500 | Rating Details | |
2024-08-17 17:31:05 -0500 | Rating Details | |
2024-08-17 17:17:11 -0500 | Rating Details | |
2024-08-17 17:08:29 -0500 | Rating Details | |
2024-08-17 17:07:12 -0500 | Rating Details | |
2024-08-17 17:06:25 -0500 | Rating Details | |
2024-08-17 17:03:03 -0500 | Rating Details | |
2024-08-17 16:56:04 -0500 | Rating Details | |
2024-08-17 16:16:41 -0500 | Rating Details | |
2024-08-17 16:10:06 -0500 | Rating Details | |
2024-08-19 03:22:03 -0500 | Rating Details | |
2024-08-18 04:04:51 -0500 | Rating Details | |
2024-08-18 02:58:43 -0500 | Rating Details | |
2024-08-18 01:57:50 -0500 | Rating Details | |
2024-08-18 01:44:16 -0500 | Rating Details | |
2024-08-18 01:31:53 -0500 | Rating Details | |
2024-08-17 20:53:36 -0500 | Rating Details | |
2024-08-17 20:00:58 -0500 | Rating Details | |
2024-08-17 19:15:59 -0500 | Rating Details | |
2024-08-17 19:05:02 -0500 | Rating Details | |
2024-08-17 19:03:23 -0500 | Rating Details | |
2024-08-17 18:58:13 -0500 | Rating Details | |
2024-08-17 18:36:41 -0500 | Rating Details | |
2024-08-17 18:14:16 -0500 | Rating Details | |
2024-08-17 17:55:58 -0500 | Rating Details | |
2024-08-17 17:53:29 -0500 | Rating Details | |
2024-08-17 17:36:06 -0500 | Rating Details | |
2024-08-17 17:24:36 -0500 | Rating Details | |
2024-08-17 16:57:09 -0500 | Rating Details | |
2024-08-17 16:25:00 -0500 | Rating Details | |
2024-09-08 11:29:35 -0500 | Rating Details |